# Franklin BSP Capital Corp: overview FRBP · OTC · CIK 1825248 · [Other](/sectors/other.md) · fiscal year ends Dec 31 Pages: [Overview](/companies/frbp.md) · [Financials](/companies/frbp/financials.md) · [Filings](/companies/frbp/filings.md) · [Insiders](/companies/frbp/insiders.md) Revenue is not reported in this company’s XBRL financial statements. ## Last eight quarters | Line item | Unit | Q3 FY2024 (2024-09-30) | Q4 FY2024 (2024-12-31) | Q1 FY2025 (2025-03-31) | Q2 FY2025 (2025-06-30) | Q3 FY2025 (2025-09-30) | Q4 FY2025 (2025-12-31) | Q1 FY2026 (2026-03-31) | Q2 FY2026 (2026-06-30) | | --- | --- | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | | Revenue | $ | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported | | Gross margin | % | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported | | Operating margin | % | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported | | Net margin | % | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported | | Diluted EPS | $ per share | [0.21](/filings/0001825248-25-000022.md) | not reported | [0.17](/filings/0001825248-26-000017.md) | [0.18](/filings/0001825248-26-000024.md) | [0.17](/filings/0001825248-25-000022.md) | not reported | [0.13](/filings/0001825248-26-000017.md) | [0.19](/filings/0001825248-26-000024.md) | | Free cash flow | $ | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported | - Revenue. XBRL not reported. - Gross margin (gross profit / revenue). XBRL not reported. - Operating margin (operating income / revenue). XBRL not reported. - Net margin (net income / revenue). XBRL Net income: us-gaap:NetIncomeLoss. Derived values: 12-month figure less the 9-month figure. - Diluted EPS. XBRL Diluted EPS: us-gaap:EarningsPerShareDiluted. - Free cash flow (operating cash flow − capital expenditure). XBRL Operating cash flow: us-gaap:NetCashProvidedByUsedInOperatingActivities. Derived values: 9-month figure less the 6-month figure; 12-month figure less the 9-month figure; 6-month figure less the 3-month figure. ## Last five fiscal years | Line item | Unit | FY (2021-12-31) | FY2022 (2022-12-31) | FY2023 (2023-12-31) | FY2024 (2024-12-31) | FY2025 (2025-12-31) | | --- | --- | ---: | ---: | ---: | ---: | ---: | | Revenue | $ | not reported | not reported | not reported | not reported | not reported | | Gross margin | % | not reported | not reported | not reported | not reported | not reported | | Operating margin | % | not reported | not reported | not reported | not reported | not reported | | Net margin | % | not reported | not reported | not reported | not reported | not reported | | Diluted EPS | $ per share | [1.30](/filings/0001825248-24-000007.md) | [1.12](/filings/0001825248-25-000004.md) | [1.41](/filings/0001825248-26-000007.md) | [0.64](/filings/0001825248-26-000007.md) | [0.73](/filings/0001825248-26-000007.md) | | Free cash flow | $ | not reported | not reported | not reported | not reported | not reported | - Revenue. XBRL not reported. - Gross margin (gross profit / revenue). XBRL not reported. - Operating margin (operating income / revenue). XBRL not reported. - Net margin (net income / revenue). XBRL Net income: us-gaap:NetIncomeLoss. - Diluted EPS. XBRL Diluted EPS: us-gaap:EarningsPerShareDiluted. - Free cash flow (operating cash flow − capital expenditure). XBRL Operating cash flow: us-gaap:NetCashProvidedByUsedInOperatingActivities. Each value links to the filing it came from. d marks a derived value. A ratio is not reported when any input is missing. ## Insider purchases and sales The last 20 open-market transactions on Form 4 (codes P and S). Reported price is as stated on the form, not a market price. [All insider transactions](/companies/frbp/insiders.md) None in coverage. ## Funds that report holding it From each manager’s latest Form 13F, largest reported value first. Reported value is as filed: filing data, not a price. [All funds](/funds.md) | Fund | Quarter ended | Reported value | Shares | Put or call | Change on the quarter before | | --- | --- | ---: | ---: | --- | --- | | [Financial Gravity Asset Management, Inc.](/funds/1741736.md) | 2026-03-31 | $858.2k | 63,194 | | Not compared | | [Financial Gravity Companies, Inc.](/funds/1377167.md) | 2026-06-30 | $842.7k | 62,565 | | Not compared | | [Your Advocates Ltd., LLP](/funds/1774437.md) | 2026-06-30 | $70.0k | 5,198 | | New +5,198 | | [Luminist Capital LLC](/funds/1807270.md) | 2026-06-30 | $4.8k | 356 | | New +356 | | [Main Street Group, LTD](/funds/1965796.md) | 2026-06-30 | $2.4k | 182 | | Unchanged | | [HANTZ FINANCIAL SERVICES, INC.](/funds/1071061.md) | 2026-06-30 | $113 | 8,362 | | Added +19 | | [VESTOR CAPITAL, LLC](/funds/1132699.md) | 2026-06-30 | $48 | 487 | | Reduced −4,257 | ## Recent filings [All 196 filings](/companies/frbp/filings.md) | Filed | Accepted | Form | What it is | Accession | | --- | --- | --- | --- | --- | | 2026-10-30 | 16:05 ET | [8-K](/filings/0001213900-26-114378.md) | 1.01 Entry into a material agreement; 2.03 New direct financial obligation; 9.01 Financial statements and exhibits | 0001213900-26-114378 | | 2026-08-12 | 13:59 ET | [10-Q](/filings/0001825248-26-000024.md) | Quarterly report, period 2026-06-30 | 0001825248-26-000024 | | 2026-07-30 | 16:05 ET | [8-K](/filings/0001213900-26-083324.md) | 5.02 Departure or appointment of officers or directors | 0001213900-26-083324 | | 2026-06-29 | 17:05 ET | [8-K](/filings/0001213900-26-073189.md) | 5.07 Shareholder vote results | 0001213900-26-073189 | | 2026-05-13 | 16:24 ET | [10-Q](/filings/0001825248-26-000017.md) | Quarterly report, period 2026-03-31 | 0001825248-26-000017 | | 2026-05-08 | 16:34 ET | [8-K](/filings/0001213900-26-053936.md) | 5.02 Departure or appointment of officers or directors | 0001213900-26-053936 | | 2026-04-16 | 15:05 ET | [8-K](/filings/0001213900-26-044556.md) | 1.01 Entry into a material agreement; 2.03 New direct financial obligation; 9.01 Financial statements and exhibits | 0001213900-26-044556 | | 2026-04-14 | 15:41 ET | [DEF 14A](/filings/0001213900-26-043498.md) | Proxy statement, period 2026-06-05 | 0001213900-26-043498 | | 2026-03-16 | 16:43 ET | [10-K](/filings/0001825248-26-000007.md) | Annual report, period 2025-12-31 | 0001825248-26-000007 | | 2026-01-29 | 17:01 ET | [8-K](/filings/0001213900-26-009596.md) | 5.02 Departure or appointment of officers or directors | 0001213900-26-009596 | ## Latest annual report [Form 10-K for the fiscal year ended Dec 31, 2025](/filings/0001825248-26-000007.md), filed Mar 16, 2026. ## Forecast league Not in this season’s league. [This season’s league](/leagues.md) ## About the filer - CIK: 1825248 - Tickers: FRBP - Exchange: OTC - SIC code: not reported - State of incorporation: DE - Filer category: Non-accelerated filer
Emerging growth company Source: SEC EDGAR, XBRL company facts, the filing index and Forms 4. Last ingested by Listed: Oct 30, 2026, 16:11 ET. No prices; not investment advice.